Orin
STZNYSE·Beverages - Wineries & Distilleries

Constellation Brands, Inc. STZ

Market cap $19.5BP/E 10.9× trailingGross margin 52.6%Reports Mon 5 Oct, after the close
$113.98
−0.23 (−0.20%)live 11:25 ET
52-wk $113.33 – $168.60
Watch
Orin's take
0.60conviction · moderate
Refreshed 24 Sep · take v6. A new filing or a print queues the next refresh.

STZ is a contrarian buy at $116.57 with RSI at 28.2 and P/E of 11.1x — roughly 35% below the peer median of 17.1x — as the fundamental trajectory improves. Revenue decline has decelerated sharply from -15.0% YoY in Q2 FY2026 to -3.3% in Q1 FY2027 (quarter ended 2026-05-31), FY2026 profitability recovered to $1.69B net income (EPS $9.61) from an $81M loss in FY2025, and management reaffirmed its full-year outlook on September 13, 2026 while redeeming $600M of 4.350% Senior Notes due 2027.

The stock is deeply oversold and cheap, with smart money sentiment marginally positive at 0.0079 as of 2026-06-30 and 63 funds holding positions, up from 55 a year earlier.

What could go wrong

  • Revenue still declining. Despite deceleration, top-line growth remains negative at -3.3% in the most recent quarter (Q1 FY2027, ended 2026-05-31); a return to positive growth is not yet confirmed.
  • Technical downtrend. Stock trades at $116.57, well below both the 50-day MA ($129.72) and 200-day MA ($144.37), with MACD histogram negative at -0.72.
  • Persistent insider selling. Net insider disposition of 81,053,029 shares over 24 months with no open-market cluster buy; recent July 2026 transactions are RSU grants, not discretionary purchases.
  • Elevated debt load. Total debt stands at $11.2B as of FY2026 (ended 2026-02-28), though the announced $600M note redemption signals active deleveraging.

What would change my mind

Q2 FY2027 earnings (Oct 6). Revenue returns to positive YoY growth or management raises full-year guidancebullish
50-day MA reclaim. Stock closes above $129.72 (50-day MA), confirming technical stabilizationbullish
Revenue re-acceleration of decline. Q2 FY2027 revenue decline widens beyond -5% YoY or guidance is loweredbearish

Where this comes from: quarterly_results Q2 FY2026 and Q1 FY2027 revenue_yoy_pct · fundamentals FY2026 and FY2025 · peer_relative pe and pe_vs_median_pct · technicals as of 2026-09-23. Orin's read on STZ; not advice.

Twelve months actual closes to 2026-09-24 · actual filings

Sept 25Nov 25Jan 26Mar 26May 26Jul 26

50-day average 200-day average · volume below

Largest holders · 13F Q2 2026

Money flow
FilerPositionOf fund
Capital World Investors$1.6B0.2% of fund
Vanguard Capital Management$1.3B0.0% of fund
Vanguard Portfolio Management$1.1B0.0% of fund
State Street$944.3M0.0% of fund
Fmr$639.9M0.0% of fund
Wellington Management Group Llp$531.0M0.1% of fund

94 filers · quarter ended Q2 2026 · positions, not flows

Insiders, last 24 months: 151 Form 4 filings, net $65.2M. Of the 50 on hand, 0 were open-market purchases and 2 sales— the rest are grants, option exercises and tax withholding.

Ask Orin about STZ

its filings · its transcripts · its numbers

Orin answers questions about STZ from its filings, transcripts and numbers — with the source behind every claim. Your own desk starts with 3 free days, card required.

Start 3 free days →

Where it trades

vs its own 5y · Consumer Defensive
MetricNowOwn medianSector
P/E10.9×—38.3×
EV/EBITDA9.1×47.8×—
P/S2.15×4.56×—
P/B2.4×4.6×—

Its P/E sits 60th percentile of its own last 5 years (+1.03σ from its own mean).

What the price assumes

-0.7%

free-cash-flow growth every year for 10 years, discounted at 10%, is what today’s price implies — starting from $1.8B of trailing free cash flow. It is an assumption the market is making, not a forecast Orin is making.

What Wall Street published

46 firms · 2026-09-24
Consensus target

$157

$122 – $185 · +37% against today's price

How they rate it
  • 25 buy or overweight
  • 20 hold
  • 1 underweight or sell

The analysts’ consensus and their own ratings, not Orin’s. A target is a twelve-month opinion published by the firm that wrote it.

Against the companies it is compared to

median P/E 19.1× of 6 peers
CompanyMarket capP/EEV/EBITDAGrossNetROE
STZConstellation Brands, Inc.$20B10.9×9.1×52.6%20.1%23%
BF-BBrown-Forman Corporation$12B16.9×13.4×60.7%18.4%18%
BGBunge Global S.A.$21B21.4×14.9×4.9%1.1%6%
CHDChurch & Dwight Co., Inc.$23B30.6×20.3×45.6%12.0%18%
DGDollar General Corporation$27B15.9×12.7×31.2%3.9%20%
DLTRDollar Tree, Inc.$22B13.8×9.9×38.7%8.0%46%
GISGeneral Mills, Inc.$19B—10.5×33.4%-4.9%-11%
TSNTyson Foods, Inc.$18B30.6×9.8×6.2%1.0%3%

The median is of the 6 peers listed above and nothing else — check it against the column. This company trades 43.1% below it. The peer set is the vendor’s, so a company can appear here that a person would not have chosen.

What it has traded at

P/E by fiscal year
FY15 26.1×FY26 16.4×

What its sector has traded at

Consumer Defensive
FY14 22.9×FY26 39.1×

Two scales, drawn separately on purpose: a sector median and one company’s multiple are not the same number and putting them on one axis invites a comparison neither series supports.

Discounted cash flow

not recomputed since
ModelFair valueAgainstComputed
Standard DCF$-59$141.03 · −142%2026-06-10
Levered DCF$264$141.03 · +87%2026-06-10

The vendor’s intrinsic-value models. Treat them as a low-growth anchor — for a fast grower the market routinely pays well above a DCF. These were computed against the price in the “against” column, not today’s.

Every estimate on one scale

price $113.98
52-week range$114 – $169
Analyst targets$122 – $185
Standard DCF$-59 as of 2026-06-10, when it was $141.03
Levered DCF$264 as of 2026-06-10, when it was $141.03
At own 5y-median P/E (-391×)$-4104
At 5y P/E range (-1016–26×)$-10657 – $277
At sector P/E (38×)$401

The vertical rule is the current price. Ranges and point estimates are the backend’s, published as they were calculated; an arrow means the estimate sits beyond this scale, and its number is on the right.